The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...

Research at Taizhou Enze Medical Center in China focused on the risk priority of adverse events during all phases of ...

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system, often emerging in early adulthood and representing a leading cause of neurological disability in young ...